SCHEMBL1845355

SCHEMBL1845355

CCNC(=O)Nc1nc2c(F)c(-c3ccnc(N4CCN(C)CC4)c3)cc(-c3ccccn3)c2s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 1/20 0.41
▸ DYRK1A Q13627 5/20 0.41
▸ KDM4E B2RXH2 1/20 0.39
▸ RAD52 P43351 1/20 0.39
▸ UBE2N P61088 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ACVR1B P36896 1/20 0.39
▸ TGFBR1 P36897 1/20 0.39
▸ ACHE P22303 1/20 0.38
▸ P2RX7 Q99572 1/20 0.38
▸ WNT1 P04628 3/20 0.38
▸ GSK3B P49841 2/20 0.38
▸ CLK2 P49760 1/20 0.38
▸ CLK3 P49761 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ ABL1 P00519 3/20 0.37
▸ USP2 O75604 1/20 0.37
▸ LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1846424 0.91 ACVR1B (0.44) TRPV4DYRK1AACVR1BTGFBR1ACHE
SCHEMBL1839976 0.85 L3MBTL1 (0.44) TRPV4KDM4EL3MBTL1ABL1
SCHEMBL1840222 0.85 FLT3 (0.41) DYRK1AKDM4EABL1
SCHEMBL1845261 0.85 RIPK1 (0.42) TRPV4DYRK1AABL1
Hydrochloric Acid SCHEMBL1845022 0.84 TNIK (0.38) TRPV4KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL1844044 0.82 HDAC2 (0.45) ACVR1BTGFBR1SMN1; SMN2NPC1RAB9A
SCHEMBL1846451 0.82 PIK3CA (0.45) ABL1
SCHEMBL1842109 0.82 MAPK1 (0.43) SMN1; SMN2NPC1RAB9AABL1
SCHEMBL4544055 0.82 LMNA (0.40) KDM4EACVR1BTGFBR1ACHEP2RX7
Hydrochloric Acid SCHEMBL4542422 0.81 LMNA (0.40) KDM4EACVR1BTGFBR1ACHEP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2011-07-07 — — US claimed
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2011-07-07 — — US disclosed
EP-2321309-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS Ranbaxy Laboratories Limited (IN) 2011-05-18 — — EP disclosed
WO-2009156966-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2009-12-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS TOP2B, TOP1, POLI TRPV4 2849/4885DYRK1A 1352/4885KDM4E 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback